Click for best price
Chronic Urticaria Or Hives Drug Market Size, Share 2022
This report contains market size and forecasts of Chronic Urticaria Or Hives Drug in global, including the following market information:
Global Chronic Urticaria Or Hives Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Urticaria Or Hives Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Chronic Urticaria Or Hives Drug companies in 2021 (%)
The global Chronic Urticaria Or Hives Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GDC-0853 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Urticaria Or Hives Drug include AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited and Merck & Co., Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chronic Urticaria Or Hives Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Urticaria Or Hives Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Type, 2021 (%)
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Global Chronic Urticaria Or Hives Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Chronic Urticaria Or Hives Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Urticaria Or Hives Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Urticaria Or Hives Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Urticaria Or Hives Drug revenues share in global market, 2021 (%)
Key companies Chronic Urticaria Or Hives Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Chronic Urticaria Or Hives Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
| Report Attributes |
Report Details |
| Report Title |
Chronic Urticaria Or Hives Drug Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Urticaria Or Hives Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Urticaria Or Hives Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Urticaria Or Hives Drug Overall Market Size
2.1 Global Chronic Urticaria Or Hives Drug Market Size: 2021 VS 2028
2.2 Global Chronic Urticaria Or Hives Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chronic Urticaria Or Hives Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Chronic Urticaria Or Hives Drug Players in Global Market
3.2 Top Global Chronic Urticaria Or Hives Drug Companies Ranked by Revenue
3.3 Global Chronic Urticaria Or Hives Drug Revenue by Companies
3.4 Global Chronic Urticaria Or Hives Drug Sales by Companies
3.5 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chronic Urticaria Or Hives Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Players in Global Market
3.8.1 List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Urticaria Or Hives Drug Market Size Markets, 2021 & 2028
4.1.2 GDC-0853
4.1.3 GSK-2646264
4.1.4 BF-Derm-1
4.1.5 Bilastine
4.1.6 Others
4.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
4.2.1 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2017-2022
4.2.2 By Type - Global Chronic Urticaria Or Hives Drug Revenue, 2023-2028
4.2.3 By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
4.3.1 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2017-2022
4.3.2 By Type - Global Chronic Urticaria Or Hives Drug Sales, 2023-2028
4.3.3 By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
4.4 By Type - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Chronic Urticaria Or Hives Drug Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
5.2.1 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2017-2022
5.2.2 By Application - Global Chronic Urticaria Or Hives Drug Revenue, 2023-2028
5.2.3 By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
5.3.1 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2017-2022
5.3.2 By Application - Global Chronic Urticaria Or Hives Drug Sales, 2023-2028
5.3.3 By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
5.4 By Application - Global Chronic Urticaria Or Hives Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Chronic Urticaria Or Hives Drug Market Size, 2021 & 2028
6.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2017-2022
6.2.2 By Region - Global Chronic Urticaria Or Hives Drug Revenue, 2023-2028
6.2.3 By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Chronic Urticaria Or Hives Drug Sales & Forecasts
6.3.1 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2017-2022
6.3.2 By Region - Global Chronic Urticaria Or Hives Drug Sales, 2023-2028
6.3.3 By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chronic Urticaria Or Hives Drug Revenue, 2017-2028
6.4.2 By Country - North America Chronic Urticaria Or Hives Drug Sales, 2017-2028
6.4.3 US Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.4.4 Canada Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.4.5 Mexico Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chronic Urticaria Or Hives Drug Revenue, 2017-2028
6.5.2 By Country - Europe Chronic Urticaria Or Hives Drug Sales, 2017-2028
6.5.3 Germany Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.4 France Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.5 U.K. Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.6 Italy Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.7 Russia Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.8 Nordic Countries Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.5.9 Benelux Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chronic Urticaria Or Hives Drug Revenue, 2017-2028
6.6.2 By Region - Asia Chronic Urticaria Or Hives Drug Sales, 2017-2028
6.6.3 China Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.6.4 Japan Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.6.5 South Korea Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.6.6 Southeast Asia Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.6.7 India Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chronic Urticaria Or Hives Drug Revenue, 2017-2028
6.7.2 By Country - South America Chronic Urticaria Or Hives Drug Sales, 2017-2028
6.7.3 Brazil Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.7.4 Argentina Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, 2017-2028
6.8.3 Turkey Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.8.4 Israel Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Chronic Urticaria Or Hives Drug Market Size, 2017-2028
6.8.6 UAE Chronic Urticaria Or Hives Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporate Summary
7.1.2 AstraZeneca Plc Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.1.5 AstraZeneca Plc Key News
7.2 Biofrontera AG
7.2.1 Biofrontera AG Corporate Summary
7.2.2 Biofrontera AG Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.2.5 Biofrontera AG Key News
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Corporate Summary
7.3.2 ELORAC, Inc. Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.3.5 ELORAC, Inc. Key News
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Corporate Summary
7.4.2 Faes Farma, SA Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Major Product Offerings
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.4.5 Faes Farma, SA Key News
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Corporate Summary
7.5.2 Genentech, Inc. Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.5.5 Genentech, Inc. Key News
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Corporate Summary
7.6.2 GlaxoSmithKline Plc Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Major Product Offerings
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.6.5 GlaxoSmithKline Plc Key News
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Corporate Summary
7.7.2 J Uriach Y Compania, S.A. Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Major Product Offerings
7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.7.5 J Uriach Y Compania, S.A. Key News
7.8 Mabtech Limited
7.8.1 Mabtech Limited Corporate Summary
7.8.2 Mabtech Limited Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.8.5 Mabtech Limited Key News
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Corporate Summary
7.9.2 Merck & Co., Inc. Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.9.5 Merck & Co., Inc. Key News
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Corporate Summary
7.10.2 Mycenax Biotech Inc. Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Major Product Offerings
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.10.5 Mycenax Biotech Inc. Key News
7.11 Novartis AG
7.11.1 Novartis AG Corporate Summary
7.11.2 Novartis AG Chronic Urticaria Or Hives Drug Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Major Product Offerings
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.11.5 Novartis AG Key News
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Corporate Summary
7.12.2 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Major Product Offerings
7.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales and Revenue in Global (2017-2022)
7.12.5 Panacea Biotec Limited Key News
8 Global Chronic Urticaria Or Hives Drug Production Capacity, Analysis
8.1 Global Chronic Urticaria Or Hives Drug Production Capacity, 2017-2028
8.2 Chronic Urticaria Or Hives Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Urticaria Or Hives Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Urticaria Or Hives Drug Supply Chain Analysis
10.1 Chronic Urticaria Or Hives Drug Industry Value Chain
10.2 Chronic Urticaria Or Hives Drug Upstream Market
10.3 Chronic Urticaria Or Hives Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chronic Urticaria Or Hives Drug in Global Market
Table 2. Top Chronic Urticaria Or Hives Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chronic Urticaria Or Hives Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chronic Urticaria Or Hives Drug Revenue Share by Companies, 2017-2022
Table 5. Global Chronic Urticaria Or Hives Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Chronic Urticaria Or Hives Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chronic Urticaria Or Hives Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 9. List of Global Tier 1 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Urticaria Or Hives Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chronic Urticaria Or Hives Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Chronic Urticaria Or Hives Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales, (K Pcs), 2023-2028
Table 46. AstraZeneca Plc Corporate Summary
Table 47. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 48. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Biofrontera AG Corporate Summary
Table 50. Biofrontera AG Chronic Urticaria Or Hives Drug Product Offerings
Table 51. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. ELORAC, Inc. Corporate Summary
Table 53. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 54. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Faes Farma, SA Corporate Summary
Table 56. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offerings
Table 57. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Genentech, Inc. Corporate Summary
Table 59. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 60. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. GlaxoSmithKline Plc Corporate Summary
Table 62. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offerings
Table 63. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. J Uriach Y Compania, S.A. Corporate Summary
Table 65. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offerings
Table 66. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Mabtech Limited Corporate Summary
Table 68. Mabtech Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 69. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Merck & Co., Inc. Corporate Summary
Table 71. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 72. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Mycenax Biotech Inc. Corporate Summary
Table 74. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offerings
Table 75. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Novartis AG Corporate Summary
Table 77. Novartis AG Chronic Urticaria Or Hives Drug Product Offerings
Table 78. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Panacea Biotec Limited Corporate Summary
Table 80. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offerings
Table 81. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Chronic Urticaria Or Hives Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 83. Global Chronic Urticaria Or Hives Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Chronic Urticaria Or Hives Drug Production by Region, 2017-2022 (K Pcs)
Table 85. Global Chronic Urticaria Or Hives Drug Production by Region, 2023-2028 (K Pcs)
Table 86. Chronic Urticaria Or Hives Drug Market Opportunities & Trends in Global Market
Table 87. Chronic Urticaria Or Hives Drug Market Drivers in Global Market
Table 88. Chronic Urticaria Or Hives Drug Market Restraints in Global Market
Table 89. Chronic Urticaria Or Hives Drug Raw Materials
Table 90. Chronic Urticaria Or Hives Drug Raw Materials Suppliers in Global Market
Table 91. Typical Chronic Urticaria Or Hives Drug Downstream
Table 92. Chronic Urticaria Or Hives Drug Downstream Clients in Global Market
Table 93. Chronic Urticaria Or Hives Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Segment by Type
Figure 2. Chronic Urticaria Or Hives Drug Segment by Application
Figure 3. Global Chronic Urticaria Or Hives Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Urticaria Or Hives Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Urticaria Or Hives Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Chronic Urticaria Or Hives Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Urticaria Or Hives Drug Revenue in 2021
Figure 9. By Type - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chronic Urticaria Or Hives Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 19. US Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 24. Germany Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 33. China Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 40. Brazil Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chronic Urticaria Or Hives Drug Sales Market Share, 2017-2028
Figure 44. Turkey Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chronic Urticaria Or Hives Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chronic Urticaria Or Hives Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Chronic Urticaria Or Hives Drug by Region, 2021 VS 2028
Figure 50. Chronic Urticaria Or Hives Drug Industry Value Chain
Figure 51. Marketing Channels
